Expanded Nestle Infant Formula Recall Affects Africa, the Americas, and Asia
Nestle’s recall of certain batches of infant nutrition products has expanded beyond Europe, affecting regions such as Africa, the Americas, and Asia. Countries including Brazil, China, and South Africa are now involved, as indicated by reports from the company and national food safety authorities.
So far, no illnesses have been confirmed in relation to the recalled batches of SMA, BEBA, NAN, and Alfamino formula. The recall was initiated due to potential contamination with cereulide, a toxin known to cause nausea and vomiting.
Health warnings regarding the potentially contaminated infant formulas have been issued in at least 37 countries. This includes most European nations, along with Australia, Brazil, China, Mexico, and South Africa.
Read more: Nestle Recalls Infant Formula Batches in 25 Countries Over Toxin Risk
This recall adds further pressure on Nestle, the maker of KitKat and Nescafe, and its new CEO, Philipp Navratil. He is working to revive growth through a comprehensive portfolio review following recent management changes. As a result of the recall, Nestle shares have dropped approximately 5.7% this week.
Brazil’s health ministry announced that the recall is a precautionary measure after the detection of the toxin in products sourced from the Netherlands. In Australia, Nestle confirmed that the recalled batches were manufactured in Switzerland, while in China, the recall pertains to formula batches imported from Europe.
According to a notice from South Africa’s National Consumer Commission, the NAN infant formula being recalled was produced in June 2025 and has a shelf life of about 18 months. The commission also noted that this product was exported to Namibia and Eswatini.
Austrian health authorities reported that the recall affects over 800 products from more than 10 factories, marking it as the largest recall in Nestle’s history. However, a spokesperson for Nestle could not confirm this information.
In response to the situation, Nestle stated that it has tested all arachidonic acid oil and related oil mixes used in the production of its potentially affected infant nutrition products. This testing was prompted by a quality issue detected in an ingredient from a leading supplier. To ensure a steady supply, the company is ramping up production and activating alternative suppliers of the acid oil.
(Reporting by Alexander Marrow in London, Igor Sodre in Sao Paulo, and Sfundo Parakozov and Anathi Madubela in Johannesburg; editing by Alexander Smith and David Goodman)
Nestle’s recall of certain batches of infant nutrition products has expanded beyond Europe, affecting regions such as Africa, the Americas, and Asia. Countries including Brazil, China, and South Africa are now involved, as indicated by reports from the company and national food safety authorities.
So far, no illnesses have been confirmed in relation to the recalled batches of SMA, BEBA, NAN, and Alfamino formula. The recall was initiated due to potential contamination with cereulide, a toxin known to cause nausea and vomiting.
Health warnings regarding the potentially contaminated infant formulas have been issued in at least 37 countries. This includes most European nations, along with Australia, Brazil, China, Mexico, and South Africa.
Read more: Nestle Recalls Infant Formula Batches in 25 Countries Over Toxin Risk
This recall adds further pressure on Nestle, the maker of KitKat and Nescafe, and its new CEO, Philipp Navratil. He is working to revive growth through a comprehensive portfolio review following recent management changes. As a result of the recall, Nestle shares have dropped approximately 5.7% this week.
Brazil’s health ministry announced that the recall is a precautionary measure after the detection of the toxin in products sourced from the Netherlands. In Australia, Nestle confirmed that the recalled batches were manufactured in Switzerland, while in China, the recall pertains to formula batches imported from Europe.
According to a notice from South Africa’s National Consumer Commission, the NAN infant formula being recalled was produced in June 2025 and has a shelf life of about 18 months. The commission also noted that this product was exported to Namibia and Eswatini.
Austrian health authorities reported that the recall affects over 800 products from more than 10 factories, marking it as the largest recall in Nestle’s history. However, a spokesperson for Nestle could not confirm this information.
In response to the situation, Nestle stated that it has tested all arachidonic acid oil and related oil mixes used in the production of its potentially affected infant nutrition products. This testing was prompted by a quality issue detected in an ingredient from a leading supplier. To ensure a steady supply, the company is ramping up production and activating alternative suppliers of the acid oil.
(Reporting by Alexander Marrow in London, Igor Sodre in Sao Paulo, and Sfundo Parakozov and Anathi Madubela in Johannesburg; editing by Alexander Smith and David Goodman)
